Skip to search formSkip to main contentSkip to account menu

WP1066

Known as: (E)-3(6-bromopyridin-2-yl)-2-cyano-N-((S0-1-phenylethyl)acrylamide, JAK2 Inhibitor WP1066 
An orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity. Upon oral administration, WP1066… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PurposeThe present study was designed to investigate the effects of WP1066, a specific inhibitor of STAT3 signaling, on radiation… 
2016
2016
Background Previous studies showed that isoflurane-induced cognitive deficits could be alleviated by dexmedetomidine in young… 
Highly Cited
2014
Highly Cited
2014
Abnormalities in signal transducer and activator of transcription 3 (STAT3) are involved in the oncogenesis of oral squamous cell… 
2012
2012
Melanoma is a common and deadly tumor that upon metastasis to the central nervous system (CNS) has median survival duration of… 
2012
2012
Background: Bv8 expression is strongly induced by G-CSF, but the mechanisms remain unknown. Results: Stat3 activation is required… 
2012
2012
Background Our previous studies indicated that MSCCXCR4 improved cardiac function after myocardial infarction (MI). This study… 
2011
2011
Maternal protein restriction diminishes placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) activity and causes fetal… 
2010
2010
Emerging evidence demonstrates the involvement of endothelin-1 (ET-1) in the pathophysiology of cardiovascular disorders… 
Highly Cited
2009
Highly Cited
2009
The activation of signal transducer and activator of transcription 3 (STAT3) has been identified as a key mediator that drives… 
2007
2007
2393 Background: Pancreatic cancer is now the fourth leading cause of cancer-related mortality in United States. Its…